A review of the safety evidence on recombinant human lactoferrin for use as a food ingredient

This publication has 77 references indexed in Scilit:

• Supplementation transgenic cow’s milk containing recombinant human lactoferrin enhances systematic and intestinal immune responses in piglets
  Molecular Biology Reports, 2014
• Consumption of transgenic cows’ milk containing human lactoferrin results in beneficial changes in the gastrointestinal tract and systemic health of young pigs
  Transgenic Research, 2012
• Differential immunogenicity and allergenicity of native and recombinant human lactoferrins: Role of glycosylation
  European Journal of Immunology, 2012
• Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors
  Investigational New Drugs, 2009
• Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma
  Cancer, 2008
• Phase I trial of oral talactoferrin alfa in refractory solid tumors
  Investigational New Drugs, 2005
• The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin
  Transgenic Research, 2005
• Direct Detection and Quantitative Determination of Bovine Lactoferricin and Lactoferrin Fragments in Human Gastric Contents by Affinity Mass Spectrometry
  1998
• Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution
  Journal of Molecular Biology, 1997
• Comparison of bovine, sheep and goat milk lactoferrins in their electrophoretic behavior, conformation, immunochemical properties and lectin reactivity
  Comparative Biochemistry and Physiology Part B: Comparative Biochemistry, 1991